author_facet Quint, Koen
Porras, Carolina
Safaeian, Mahboobeh
González, Paula
Hildesheim, Allan
Quint, Wim
van Doorn, Leen-Jan
Silva, Sandra
Melchers, Willem
Schiffman, Mark
Rodríguez, Ana Cecilia
Wacholder, Sholom
Freer, Enrique
Cortes, Bernal
Herrero, Rolando
Quint, Koen
Porras, Carolina
Safaeian, Mahboobeh
González, Paula
Hildesheim, Allan
Quint, Wim
van Doorn, Leen-Jan
Silva, Sandra
Melchers, Willem
Schiffman, Mark
Rodríguez, Ana Cecilia
Wacholder, Sholom
Freer, Enrique
Cortes, Bernal
Herrero, Rolando
author Quint, Koen
Porras, Carolina
Safaeian, Mahboobeh
González, Paula
Hildesheim, Allan
Quint, Wim
van Doorn, Leen-Jan
Silva, Sandra
Melchers, Willem
Schiffman, Mark
Rodríguez, Ana Cecilia
Wacholder, Sholom
Freer, Enrique
Cortes, Bernal
Herrero, Rolando
spellingShingle Quint, Koen
Porras, Carolina
Safaeian, Mahboobeh
González, Paula
Hildesheim, Allan
Quint, Wim
van Doorn, Leen-Jan
Silva, Sandra
Melchers, Willem
Schiffman, Mark
Rodríguez, Ana Cecilia
Wacholder, Sholom
Freer, Enrique
Cortes, Bernal
Herrero, Rolando
Journal of Clinical Microbiology
Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
Microbiology (medical)
author_sort quint, koen
spelling Quint, Koen Porras, Carolina Safaeian, Mahboobeh González, Paula Hildesheim, Allan Quint, Wim van Doorn, Leen-Jan Silva, Sandra Melchers, Willem Schiffman, Mark Rodríguez, Ana Cecilia Wacholder, Sholom Freer, Enrique Cortes, Bernal Herrero, Rolando 0095-1137 1098-660X American Society for Microbiology Microbiology (medical) http://dx.doi.org/10.1128/jcm.01155-07 <jats:title>ABSTRACT</jats:title> <jats:p> The aims of this study were to compare a novel PCR-based <jats:italic>Chlamydia trachomatis</jats:italic> detection and genotyping (Ct-DT) assay with the FDA-approved, commercially available <jats:italic>C. trachomatis</jats:italic> detection Hybrid Capture 2 (HC2) assay and to investigate the <jats:italic>C. trachomatis</jats:italic> serovar distribution among young women in a rural Costa Rican study population. A total of 5,828 sexually active women participating in a community-based trial in Costa Rica were tested for <jats:italic>C. trachomatis</jats:italic> by HC2. A sample of 1,229 specimens consisting of 100% HC2 <jats:italic>C. trachomatis</jats:italic> -positive specimens ( <jats:italic>n</jats:italic> = 827) and a random sample of 8% HC2 <jats:italic>C. trachomatis</jats:italic> -negative specimens ( <jats:italic>n</jats:italic> = 402) were tested with the Ct-DT assay. Agreement between the two assays was determined by the unweighted kappa statistic. Discrepant specimens were tested with a second commercially available test (COBAS TaqMan). The Ct-DT-positive specimens were further analyzed with the Ct-DT genotyping step to investigate the distribution of 14 different <jats:italic>C. trachomatis</jats:italic> serovars (A, B/Ba, C, D/Da, E, F, G/Ga, H, I/Ia, J, K, L1, L2/L2a, and L3). After accounting for the sampling fraction selected for Ct-DT testing, crude agreement with the HC2 assay was 98% and the kappa was 0.92 (95% confidence interval [CI], 0.89 to 0.97). The 33 discordant samples that were further analyzed with the COBAS TaqMan test showed better agreement with the Ct-DT assay (31/33, <jats:italic>P</jats:italic> &lt; 0.001). Among the 806 Ct-DT-positive samples, serovar E was the most common serovar (31%), followed by serovars F and D (both 21%) and serovar I (15%). In conclusion, the novel Ct-DT assay permits reliable detection and identification of <jats:italic>C. trachomatis</jats:italic> serovars. </jats:p> Evaluation of a Novel PCR-Based Assay for Detection and Identification of <i>Chlamydia trachomatis</i> Serovars in Cervical Specimens Journal of Clinical Microbiology
doi_str_mv 10.1128/jcm.01155-07
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMDExNTUtMDc
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMDExNTUtMDc
institution DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
imprint American Society for Microbiology, 2007
imprint_str_mv American Society for Microbiology, 2007
issn 0095-1137
1098-660X
issn_str_mv 0095-1137
1098-660X
language English
mega_collection American Society for Microbiology (CrossRef)
match_str quint2007evaluationofanovelpcrbasedassayfordetectionandidentificationofchlamydiatrachomatisserovarsincervicalspecimens
publishDateSort 2007
publisher American Society for Microbiology
recordtype ai
record_format ai
series Journal of Clinical Microbiology
source_id 49
title Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_unstemmed Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_full Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_fullStr Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_full_unstemmed Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_short Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_sort evaluation of a novel pcr-based assay for detection and identification of <i>chlamydia trachomatis</i> serovars in cervical specimens
topic Microbiology (medical)
url http://dx.doi.org/10.1128/jcm.01155-07
publishDate 2007
physical 3986-3991
description <jats:title>ABSTRACT</jats:title> <jats:p> The aims of this study were to compare a novel PCR-based <jats:italic>Chlamydia trachomatis</jats:italic> detection and genotyping (Ct-DT) assay with the FDA-approved, commercially available <jats:italic>C. trachomatis</jats:italic> detection Hybrid Capture 2 (HC2) assay and to investigate the <jats:italic>C. trachomatis</jats:italic> serovar distribution among young women in a rural Costa Rican study population. A total of 5,828 sexually active women participating in a community-based trial in Costa Rica were tested for <jats:italic>C. trachomatis</jats:italic> by HC2. A sample of 1,229 specimens consisting of 100% HC2 <jats:italic>C. trachomatis</jats:italic> -positive specimens ( <jats:italic>n</jats:italic> = 827) and a random sample of 8% HC2 <jats:italic>C. trachomatis</jats:italic> -negative specimens ( <jats:italic>n</jats:italic> = 402) were tested with the Ct-DT assay. Agreement between the two assays was determined by the unweighted kappa statistic. Discrepant specimens were tested with a second commercially available test (COBAS TaqMan). The Ct-DT-positive specimens were further analyzed with the Ct-DT genotyping step to investigate the distribution of 14 different <jats:italic>C. trachomatis</jats:italic> serovars (A, B/Ba, C, D/Da, E, F, G/Ga, H, I/Ia, J, K, L1, L2/L2a, and L3). After accounting for the sampling fraction selected for Ct-DT testing, crude agreement with the HC2 assay was 98% and the kappa was 0.92 (95% confidence interval [CI], 0.89 to 0.97). The 33 discordant samples that were further analyzed with the COBAS TaqMan test showed better agreement with the Ct-DT assay (31/33, <jats:italic>P</jats:italic> &lt; 0.001). Among the 806 Ct-DT-positive samples, serovar E was the most common serovar (31%), followed by serovars F and D (both 21%) and serovar I (15%). In conclusion, the novel Ct-DT assay permits reliable detection and identification of <jats:italic>C. trachomatis</jats:italic> serovars. </jats:p>
container_issue 12
container_start_page 3986
container_title Journal of Clinical Microbiology
container_volume 45
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792334240120045575
geogr_code not assigned
last_indexed 2024-03-01T14:25:31.139Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Evaluation+of+a+Novel+PCR-Based+Assay+for+Detection+and+Identification+of++++++++++++Chlamydia+trachomatis++++++++++++Serovars+in+Cervical+Specimens&rft.date=2007-12-01&genre=article&issn=1098-660X&volume=45&issue=12&spage=3986&epage=3991&pages=3986-3991&jtitle=Journal+of+Clinical+Microbiology&atitle=Evaluation+of+a+Novel+PCR-Based+Assay+for+Detection+and+Identification+of%0A++++++++++++%3Ci%3EChlamydia+trachomatis%3C%2Fi%3E%0A++++++++++++Serovars+in+Cervical+Specimens&aulast=Herrero&aufirst=Rolando&rft_id=info%3Adoi%2F10.1128%2Fjcm.01155-07&rft.language%5B0%5D=eng
SOLR
_version_ 1792334240120045575
author Quint, Koen, Porras, Carolina, Safaeian, Mahboobeh, González, Paula, Hildesheim, Allan, Quint, Wim, van Doorn, Leen-Jan, Silva, Sandra, Melchers, Willem, Schiffman, Mark, Rodríguez, Ana Cecilia, Wacholder, Sholom, Freer, Enrique, Cortes, Bernal, Herrero, Rolando
author_facet Quint, Koen, Porras, Carolina, Safaeian, Mahboobeh, González, Paula, Hildesheim, Allan, Quint, Wim, van Doorn, Leen-Jan, Silva, Sandra, Melchers, Willem, Schiffman, Mark, Rodríguez, Ana Cecilia, Wacholder, Sholom, Freer, Enrique, Cortes, Bernal, Herrero, Rolando, Quint, Koen, Porras, Carolina, Safaeian, Mahboobeh, González, Paula, Hildesheim, Allan, Quint, Wim, van Doorn, Leen-Jan, Silva, Sandra, Melchers, Willem, Schiffman, Mark, Rodríguez, Ana Cecilia, Wacholder, Sholom, Freer, Enrique, Cortes, Bernal, Herrero, Rolando
author_sort quint, koen
container_issue 12
container_start_page 3986
container_title Journal of Clinical Microbiology
container_volume 45
description <jats:title>ABSTRACT</jats:title> <jats:p> The aims of this study were to compare a novel PCR-based <jats:italic>Chlamydia trachomatis</jats:italic> detection and genotyping (Ct-DT) assay with the FDA-approved, commercially available <jats:italic>C. trachomatis</jats:italic> detection Hybrid Capture 2 (HC2) assay and to investigate the <jats:italic>C. trachomatis</jats:italic> serovar distribution among young women in a rural Costa Rican study population. A total of 5,828 sexually active women participating in a community-based trial in Costa Rica were tested for <jats:italic>C. trachomatis</jats:italic> by HC2. A sample of 1,229 specimens consisting of 100% HC2 <jats:italic>C. trachomatis</jats:italic> -positive specimens ( <jats:italic>n</jats:italic> = 827) and a random sample of 8% HC2 <jats:italic>C. trachomatis</jats:italic> -negative specimens ( <jats:italic>n</jats:italic> = 402) were tested with the Ct-DT assay. Agreement between the two assays was determined by the unweighted kappa statistic. Discrepant specimens were tested with a second commercially available test (COBAS TaqMan). The Ct-DT-positive specimens were further analyzed with the Ct-DT genotyping step to investigate the distribution of 14 different <jats:italic>C. trachomatis</jats:italic> serovars (A, B/Ba, C, D/Da, E, F, G/Ga, H, I/Ia, J, K, L1, L2/L2a, and L3). After accounting for the sampling fraction selected for Ct-DT testing, crude agreement with the HC2 assay was 98% and the kappa was 0.92 (95% confidence interval [CI], 0.89 to 0.97). The 33 discordant samples that were further analyzed with the COBAS TaqMan test showed better agreement with the Ct-DT assay (31/33, <jats:italic>P</jats:italic> &lt; 0.001). Among the 806 Ct-DT-positive samples, serovar E was the most common serovar (31%), followed by serovars F and D (both 21%) and serovar I (15%). In conclusion, the novel Ct-DT assay permits reliable detection and identification of <jats:italic>C. trachomatis</jats:italic> serovars. </jats:p>
doi_str_mv 10.1128/jcm.01155-07
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMDExNTUtMDc
imprint American Society for Microbiology, 2007
imprint_str_mv American Society for Microbiology, 2007
institution DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275
issn 0095-1137, 1098-660X
issn_str_mv 0095-1137, 1098-660X
language English
last_indexed 2024-03-01T14:25:31.139Z
match_str quint2007evaluationofanovelpcrbasedassayfordetectionandidentificationofchlamydiatrachomatisserovarsincervicalspecimens
mega_collection American Society for Microbiology (CrossRef)
physical 3986-3991
publishDate 2007
publishDateSort 2007
publisher American Society for Microbiology
record_format ai
recordtype ai
series Journal of Clinical Microbiology
source_id 49
spelling Quint, Koen Porras, Carolina Safaeian, Mahboobeh González, Paula Hildesheim, Allan Quint, Wim van Doorn, Leen-Jan Silva, Sandra Melchers, Willem Schiffman, Mark Rodríguez, Ana Cecilia Wacholder, Sholom Freer, Enrique Cortes, Bernal Herrero, Rolando 0095-1137 1098-660X American Society for Microbiology Microbiology (medical) http://dx.doi.org/10.1128/jcm.01155-07 <jats:title>ABSTRACT</jats:title> <jats:p> The aims of this study were to compare a novel PCR-based <jats:italic>Chlamydia trachomatis</jats:italic> detection and genotyping (Ct-DT) assay with the FDA-approved, commercially available <jats:italic>C. trachomatis</jats:italic> detection Hybrid Capture 2 (HC2) assay and to investigate the <jats:italic>C. trachomatis</jats:italic> serovar distribution among young women in a rural Costa Rican study population. A total of 5,828 sexually active women participating in a community-based trial in Costa Rica were tested for <jats:italic>C. trachomatis</jats:italic> by HC2. A sample of 1,229 specimens consisting of 100% HC2 <jats:italic>C. trachomatis</jats:italic> -positive specimens ( <jats:italic>n</jats:italic> = 827) and a random sample of 8% HC2 <jats:italic>C. trachomatis</jats:italic> -negative specimens ( <jats:italic>n</jats:italic> = 402) were tested with the Ct-DT assay. Agreement between the two assays was determined by the unweighted kappa statistic. Discrepant specimens were tested with a second commercially available test (COBAS TaqMan). The Ct-DT-positive specimens were further analyzed with the Ct-DT genotyping step to investigate the distribution of 14 different <jats:italic>C. trachomatis</jats:italic> serovars (A, B/Ba, C, D/Da, E, F, G/Ga, H, I/Ia, J, K, L1, L2/L2a, and L3). After accounting for the sampling fraction selected for Ct-DT testing, crude agreement with the HC2 assay was 98% and the kappa was 0.92 (95% confidence interval [CI], 0.89 to 0.97). The 33 discordant samples that were further analyzed with the COBAS TaqMan test showed better agreement with the Ct-DT assay (31/33, <jats:italic>P</jats:italic> &lt; 0.001). Among the 806 Ct-DT-positive samples, serovar E was the most common serovar (31%), followed by serovars F and D (both 21%) and serovar I (15%). In conclusion, the novel Ct-DT assay permits reliable detection and identification of <jats:italic>C. trachomatis</jats:italic> serovars. </jats:p> Evaluation of a Novel PCR-Based Assay for Detection and Identification of <i>Chlamydia trachomatis</i> Serovars in Cervical Specimens Journal of Clinical Microbiology
spellingShingle Quint, Koen, Porras, Carolina, Safaeian, Mahboobeh, González, Paula, Hildesheim, Allan, Quint, Wim, van Doorn, Leen-Jan, Silva, Sandra, Melchers, Willem, Schiffman, Mark, Rodríguez, Ana Cecilia, Wacholder, Sholom, Freer, Enrique, Cortes, Bernal, Herrero, Rolando, Journal of Clinical Microbiology, Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens, Microbiology (medical)
title Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_full Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_fullStr Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_full_unstemmed Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_short Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
title_sort evaluation of a novel pcr-based assay for detection and identification of <i>chlamydia trachomatis</i> serovars in cervical specimens
title_unstemmed Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens
topic Microbiology (medical)
url http://dx.doi.org/10.1128/jcm.01155-07